Correlation Between Aegon NV and ArriVent BioPharma,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aegon NV and ArriVent BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aegon NV and ArriVent BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aegon NV ADR and ArriVent BioPharma, Common, you can compare the effects of market volatilities on Aegon NV and ArriVent BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aegon NV with a short position of ArriVent BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aegon NV and ArriVent BioPharma,.

Diversification Opportunities for Aegon NV and ArriVent BioPharma,

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between Aegon and ArriVent is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Aegon NV ADR and ArriVent BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ArriVent BioPharma, and Aegon NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aegon NV ADR are associated (or correlated) with ArriVent BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ArriVent BioPharma, has no effect on the direction of Aegon NV i.e., Aegon NV and ArriVent BioPharma, go up and down completely randomly.

Pair Corralation between Aegon NV and ArriVent BioPharma,

Considering the 90-day investment horizon Aegon NV ADR is expected to generate 0.52 times more return on investment than ArriVent BioPharma,. However, Aegon NV ADR is 1.92 times less risky than ArriVent BioPharma,. It trades about 0.0 of its potential returns per unit of risk. ArriVent BioPharma, Common is currently generating about -0.07 per unit of risk. If you would invest  633.00  in Aegon NV ADR on September 15, 2024 and sell it today you would lose (2.00) from holding Aegon NV ADR or give up 0.32% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.45%
ValuesDaily Returns

Aegon NV ADR  vs.  ArriVent BioPharma, Common

 Performance 
       Timeline  
Aegon NV ADR 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Aegon NV ADR are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable technical and fundamental indicators, Aegon NV is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
ArriVent BioPharma, 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in ArriVent BioPharma, Common are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile fundamental drivers, ArriVent BioPharma, may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Aegon NV and ArriVent BioPharma, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aegon NV and ArriVent BioPharma,

The main advantage of trading using opposite Aegon NV and ArriVent BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aegon NV position performs unexpectedly, ArriVent BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ArriVent BioPharma, will offset losses from the drop in ArriVent BioPharma,'s long position.
The idea behind Aegon NV ADR and ArriVent BioPharma, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges